YellowGrade
What Drives Newly Minted CRISPR Unicorn Mammoth Biosciences

Sept. 27, 2021, 6:16 a.m.

(Forbes) Mammoth Biosciences has raised $195 million to build next-generation CRISPR products in therapeutics and diagnostics that can cure and detect diseases. Mammoth has now reached unicorn status in the industry with a valuation of more than $1 billion.

Login to grade this article.